Bringing decades of large pharma expertiese to your organisation

Decades of large pharma and diagnostic experience

Core Precision works with pharma, biotech and life science organisations delivering precision/personalised medicine operational and strategic support

We have decades of large pharma and diagnostic expertise in progressing numerous therapies, alongside companion diagnostics. Companies include:

  • Novartis

  • GSK

  • Astrazeneca

  • Bristol Myers Squibb

  • Merck

  • Lonza

  • Pierre Fabre

  • Roche

  • Qiagen

Specialist knowledge leading to regulatory and commercial success

We have extensive and specialist knowledge of various disease areas, diagnostic technologies and drug co-development stages as well as launch readiness and post launch activities

Our expert knowledge helps companies fill the gap in their capability needs with bespoke arrangements.

Core Precision’s mission is to work with companies to overcome strategic obstacles to realise the full potential of their therapies and diagnostics, helping forge a path to regulatory and commercial success.

Proven development and commercialisation of precision medicines

Core Precision have contributed to the development and commercialisation of numerous precision medicines including:

  • IRESSA®

  • LYNPARZA®

  • TAGRISSO®

Our expertise ranges from drug-diagnostic co-development through to launch readiness and ensuring market uptake of novel drugs and diagnostics.

That ranges from discovery through to clinical development, and from successful launches to uptake in countries around the world.